Spurred by the discoveries of human pluripotent stem cell culture by James Thomson in the 1990s and the induction of pluripotency from adult cells by Shinya Yamanaka in the 2000s, therapeutics derived ...
Upstream Bio, Inc. (UPB) completed its IPO back in October 2024, raising approximately $293 million. This biotech is placing itself in a good position to do well because it is leveraging an entirely ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile